Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Insulin synthesized in the paraventricular nucleus of the hypothalamus regulates pituitary growth hormone production
Jaemeun Lee, … , Yong Chul Bae, Eun-Kyoung Kim
Jaemeun Lee, … , Yong Chul Bae, Eun-Kyoung Kim
Published July 9, 2020
Citation Information: JCI Insight. 2020;5(16):e135412. https://doi.org/10.1172/jci.insight.135412.
View: Text | PDF
Research Article Endocrinology Neuroscience

Insulin synthesized in the paraventricular nucleus of the hypothalamus regulates pituitary growth hormone production

  • Text
  • PDF
Abstract

Evidence has mounted that insulin can be synthesized in various brain regions, including the hypothalamus. However, the distribution and functions of insulin-expressing cells in the hypothalamus remain elusive. Herein, we show that in the mouse hypothalamus, the perikarya of insulin-positive neurons are located in the paraventricular nucleus (PVN) and their axons project to the median eminence; these findings define parvocellular neurosecretory PVN insulin neurons. Contrary to corticotropin-releasing hormone expression, insulin expression in the PVN was inhibited by restraint stress (RS) in both adult and young mice. Acute RS–induced inhibition of PVN insulin expression in adult mice decreased both pituitary growth hormone (Gh) mRNA level and serum GH concentration, which were attenuated by overexpression of PVN insulin. Notably, PVN insulin knockdown or chronic RS in young mice hindered normal growth via the downregulation of GH gene expression and secretion, whereas PVN insulin overexpression in young mice prevented chronic RS–induced growth retardation by elevating GH production. Our results suggest that in both normal and stressful conditions, insulin synthesized in the parvocellular PVN neurons plays an important role in the regulation of pituitary GH production and body length, unveiling a physiological function of brain-derived insulin.

Authors

Jaemeun Lee, Kyungchan Kim, Jae Hyun Cho, Jin Young Bae, Timothy P. O’Leary, James D. Johnson, Yong Chul Bae, Eun-Kyoung Kim

×

Figure 2

PVN insulin neurons project to the external zone of the ME, thereby cotransporting insulin and CRH from the PVN to the ME.

Options: View larger image (or click on image) Download as PowerPoint
PVN insulin neurons project to the external zone of the ME, thereby cotr...
(A) A confocal image of double immunostaining for proinsulin and FG in the PVN of mice i.p. injected with FG. Open arrowheads indicate single proinsulin labeling. Solid arrowheads show colocalization. (B and C) Taken 2 weeks after injection of GFP-expressing lentivirus into the PVN, a confocal image of GFP expression in the PVN (B) and of double immunostaining for C-peptide and GFP in the ME (C). Solid arrowheads show colocalization. (D–G) Confocal images of the PVN and ME from fed and 24-hour fasted mice and qRT-PCR analysis of Ins2 mRNA levels in the microdissected PVN. The PVN was immunostained for proinsulin (D) and the ME for C-peptide (E). Quantification of fluorescence intensity of proinsulin-immunoreactive cells in the PVN and C-peptide–immunoreactive nerve terminals in the ME (F). Relative levels of Ins2 mRNA in the PVN (G). (H–J) Confocal images of double immunostaining for mCRH and C-peptide 48 hours after vehicle or colchicine injection. PVN (H) and ME (I) at low magnification (H). PVN at high magnification (J). (K) Double immunogold labeling showing colocalization of mCRH and C-peptide within the same neurosecretory granules in an axon nerve terminal located in the ME. An arrowhead indicates an mCRH-immunoreactive 12 nm gold particle. An arrow denotes a C-peptide–immunoreactive 30 nm gold particle. Data are shown as mean ± SEM, 2-tailed unpaired Student’s t test. ** P < 0.01, n = 4 mice/group (F), n = 6 mice/group (G). Scale bars: 50 μm (A, B, D, H, and I), 20 μm (C, E, and high-magnification inset images in A), 10 μm (J), 100 nm (K).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts